Sanofi (NASDAQ:SNY) Position Raised by OLD National Bancorp IN

OLD National Bancorp IN grew its position in shares of Sanofi (NASDAQ:SNY) by 12.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 24,373 shares of the company’s stock after purchasing an additional 2,790 shares during the quarter. OLD National Bancorp IN’s holdings in Sanofi were worth $1,176,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of the company. Stablepoint Partners LLC grew its position in Sanofi by 0.8% in the 3rd quarter. Stablepoint Partners LLC now owns 23,893 shares of the company’s stock worth $1,377,000 after purchasing an additional 189 shares during the last quarter. Abel Hall LLC grew its holdings in Sanofi by 1.8% in the 4th quarter. Abel Hall LLC now owns 10,990 shares of the company’s stock worth $530,000 after buying an additional 194 shares in the last quarter. PDS Planning Inc grew its holdings in Sanofi by 3.1% in the 3rd quarter. PDS Planning Inc now owns 6,643 shares of the company’s stock worth $383,000 after buying an additional 200 shares in the last quarter. Eagle Ridge Investment Management raised its stake in Sanofi by 3.8% during the 3rd quarter. Eagle Ridge Investment Management now owns 5,571 shares of the company’s stock valued at $321,000 after acquiring an additional 203 shares in the last quarter. Finally, Financial Advocates Investment Management raised its stake in Sanofi by 3.4% during the 3rd quarter. Financial Advocates Investment Management now owns 6,327 shares of the company’s stock valued at $365,000 after acquiring an additional 206 shares in the last quarter. Institutional investors own 14.04% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently commented on SNY shares. StockNews.com lowered Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, December 12th. Deutsche Bank Aktiengesellschaft raised shares of Sanofi from a “sell” rating to a “hold” rating in a research note on Thursday. Two research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $60.00.

Sanofi Stock Up 0.4 %

Shares of SNY stock opened at $54.34 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.65 and a current ratio of 1.00. The stock has a market cap of $137.91 billion, a PE ratio of 27.72, a price-to-earnings-growth ratio of 1.21 and a beta of 0.57. The business’s fifty day moving average is $49.24 and its 200-day moving average is $52.27. Sanofi has a 1 year low of $45.22 and a 1 year high of $58.97.

Sanofi (NASDAQ:SNY) last issued its quarterly earnings results on Thursday, January 30th. The company reported $0.70 EPS for the quarter, hitting the consensus estimate of $0.70. Sanofi had a net margin of 9.96% and a return on equity of 27.45%. Equities analysts expect that Sanofi will post 3.82 earnings per share for the current fiscal year.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.